1. Home
  2. STRO vs CPBI Comparison

STRO vs CPBI Comparison

Compare STRO & CPBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STRO
  • CPBI
  • Stock Information
  • Founded
  • STRO 2003
  • CPBI 2023
  • Country
  • STRO United States
  • CPBI United States
  • Employees
  • STRO N/A
  • CPBI N/A
  • Industry
  • STRO Biotechnology: Biological Products (No Diagnostic Substances)
  • CPBI
  • Sector
  • STRO Health Care
  • CPBI
  • Exchange
  • STRO Nasdaq
  • CPBI Nasdaq
  • Market Cap
  • STRO 68.1M
  • CPBI 68.6M
  • IPO Year
  • STRO 2018
  • CPBI N/A
  • Fundamental
  • Price
  • STRO $0.88
  • CPBI $15.99
  • Analyst Decision
  • STRO Hold
  • CPBI
  • Analyst Count
  • STRO 7
  • CPBI 0
  • Target Price
  • STRO $1.97
  • CPBI N/A
  • AVG Volume (30 Days)
  • STRO 980.5K
  • CPBI 7.4K
  • Earning Date
  • STRO 11-12-2025
  • CPBI 01-01-0001
  • Dividend Yield
  • STRO N/A
  • CPBI N/A
  • EPS Growth
  • STRO N/A
  • CPBI 0.69
  • EPS
  • STRO N/A
  • CPBI 0.98
  • Revenue
  • STRO $104,473,000.00
  • CPBI $19,464,000.00
  • Revenue This Year
  • STRO $65.48
  • CPBI N/A
  • Revenue Next Year
  • STRO N/A
  • CPBI N/A
  • P/E Ratio
  • STRO N/A
  • CPBI $16.60
  • Revenue Growth
  • STRO N/A
  • CPBI 9.30
  • 52 Week Low
  • STRO $0.52
  • CPBI $13.00
  • 52 Week High
  • STRO $4.60
  • CPBI $16.71
  • Technical
  • Relative Strength Index (RSI)
  • STRO 51.76
  • CPBI 49.53
  • Support Level
  • STRO $0.77
  • CPBI $16.15
  • Resistance Level
  • STRO $0.89
  • CPBI $16.27
  • Average True Range (ATR)
  • STRO 0.07
  • CPBI 0.07
  • MACD
  • STRO -0.00
  • CPBI -0.04
  • Stochastic Oscillator
  • STRO 50.62
  • CPBI 5.00

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

About CPBI Central Plains Bancshares Inc.

Central Plains Bancshares Inc operates as the bank holding company for Home Federal Savings and Loan Association of Grand Island that provides mortgage, consumer, commercial real estate, and commercial loans, The bank business consists mainly of accepting deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in primary market area, as well as commercial real estate loans.

Share on Social Networks: